COSM 📈 Cosmos Health - Overview
Exchange: NASDAQ • Country: United States • Currency: USD • Type: Common Stock • ISIN: US2214132068
COSM: Vitamins, Minerals, Dietary, Medicines, Medical Devices, Baby Products
Cosmos Health Inc. manufactures, develops, and trades branded nutraceutical products in Greece, the United Kingdom, Croatia, Bulgaria, Cayman Islands, and Cyprus. It offers medicines, OTC medicines, nutraceutical products, vitamins, minerals and dietary, health care products, medical devices, baby products, and others under the Sky Premium Life and Mediterranation brand names. The company serves wholesale distributors and other healthcare providers, such as clinics, government agencies, independent retail and specialty pharmacies and independent specialty distributors. It sells its products through independent wholesale distributors. Cosmos Health Inc. was incorporated in 2009 and is headquartered in Chicago, Illinois. Web URL: https://www.cosmosholdingsinc.com
Additional Sources for COSM Stock
News:
Wall Street Journal
Benzinga
Yahoo Finance
Tweets: X Stocktwits
Fund Manager Positions: Dataroma Stockcircle
Tweets: X Stocktwits
Fund Manager Positions: Dataroma Stockcircle
COSM Stock Overview
| Market Cap in USD | 16m |
| Sector | Healthcare |
| Industry | Medical Distribution |
| GiC Sub-Industry | Health Care Distributors |
| IPO / Inception | 2012-10-11 |
COSM Stock Ratings
| Growth 5y | -82.3% |
| Fundamental | -37.3% |
| Dividend | - |
| Rel. Strength Industry | -1677 |
| Analysts | 4/5 |
| Fair Price Momentum | 0.38 USD |
| Fair Price DCF | - |
COSM Dividends
No Dividends PaidCOSM Growth Ratios
| Growth Correlation 3m | -51.3% |
| Growth Correlation 12m | -5.2% |
| Growth Correlation 5y | -88.3% |
| CAGR 5y | -59.55% |
| CAGR/Mean DD 5y | -0.87 |
| Sharpe Ratio 12m | -0.05 |
| Alpha | -48.58 |
| Beta | 0.28 |
| Volatility | 97.45% |
| Current Volume | 968.6k |
| Average Volume 20d | 200.3k |
What is the price of COSM stocks?
As of January 15, 2025, the stock is trading at USD 0.69 with a total of 968,629 shares traded.
Over the past week, the price has changed by -12.71%, over one month by -15.37%, over three months by -16.72% and over the past year by -45.45%.
As of January 15, 2025, the stock is trading at USD 0.69 with a total of 968,629 shares traded.
Over the past week, the price has changed by -12.71%, over one month by -15.37%, over three months by -16.72% and over the past year by -45.45%.
Is Cosmos Health a good stock to buy?
Probably not. Based on ValueRay Fundamental Analyses, Cosmos Health (NASDAQ:COSM) is currently (January 2025) not a good stock to buy. It has a ValueRay Fundamental Rating of -37.31 and therefor a somewhat negative outlook according to the companies health.
Based on ValueRays Analyses, Dividends and Discounted-Cash-Flow, the Fair Value of COSM as of January 2025 is 0.38. This means that COSM is currently overvalued and has a potential downside of -44.93%.
Probably not. Based on ValueRay Fundamental Analyses, Cosmos Health (NASDAQ:COSM) is currently (January 2025) not a good stock to buy. It has a ValueRay Fundamental Rating of -37.31 and therefor a somewhat negative outlook according to the companies health.
Based on ValueRays Analyses, Dividends and Discounted-Cash-Flow, the Fair Value of COSM as of January 2025 is 0.38. This means that COSM is currently overvalued and has a potential downside of -44.93%.
Is COSM a buy, sell or hold?
Cosmos Health has received a consensus analysts rating of 4.00. Therefor, it is recommend to buy COSM.
Cosmos Health has received a consensus analysts rating of 4.00. Therefor, it is recommend to buy COSM.
- Strong Buy: 0
- Buy: 1
- Hold: 0
- Sell: 0
- Strong Sell: 0
What are the forecast for COSM stock price target?
According to ValueRays Forecast Model, COSM Cosmos Health will be worth about 0.4 in January 2026. The stock is currently trading at 0.69. This means that the stock has a potential downside of -40.58%.
According to ValueRays Forecast Model, COSM Cosmos Health will be worth about 0.4 in January 2026. The stock is currently trading at 0.69. This means that the stock has a potential downside of -40.58%.
| Issuer | Forecast | Upside |
|---|---|---|
| Wallstreet Target Price | 3 | 334.8% |
| Analysts Target Price | 3 | 334.8% |
| ValueRay Target Price | 0.4 | -40.6% |